Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Record History shows the latest version updated to Revision: v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s software/interface revision indicator updates from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/version deployment rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedNew revision added to the record history: v3.5.0 appears, indicating updates since the previous revision (v3.4.3).SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the Record History.SummaryDifference0.1%

- Check102 days agoChange DetectedA new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.